Cargando…

Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg

C5aR signaling plays an important role in the regulation of T cell activation and alloimmune responses in chronic graft-versus-host disease (cGVHD). However, direct evidence of this modulation and the efficacy of C5aR blockade in the treatment of cGVHD have not been demonstrated. We observed higher...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yulian, Lai, Peilong, Chen, Xiaomei, He, Chang, Huang, Xin, Geng, Suxia, Luo, Chenwei, Wu, Suijing, Ling, Wei, Zhong, Liye, Lu, Zesheng, Li, Peng, Weng, Jianyu, Du, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472632/ https://www.ncbi.nlm.nih.gov/pubmed/28620195 http://dx.doi.org/10.1038/s41598-017-03700-1

Ejemplares similares

A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD
por: Lai, Peilong, et al.
Publicado: (2018)

Toll-like receptor 2–mediated NF-κB inflammatory responses in dry eye associated with cGVHD
por: He, Chang, et al.
Publicado: (2011)

Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting
por: Afram, Gabriel, et al.
Publicado: (2018)

Progress of cGVHD pathogenesis from the perspective of B cells
por: Li, Xiaoping, et al.
Publicado: (2019)

Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation
por: Shokouhi, Shabnam, et al.
Publicado: (2015)

C3aR costimulation enhances the antitumor efficacy of CAR-T cell therapy through Th17 expansion and memory T cell induction
por: Lai, Peilong, et al.
Publicado: (2022)

Chronic Graft-Versus-Host Disease (cGVHD) Exacerbation after Sars-Cov-2 Covid Vaccination
por: Trunk, Andrew D., et al.
Publicado: (2021)

The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation
por: Metafuni, Elisabetta, et al.
Publicado: (2022)

Lupus Recipe inhibits cGVHD‐induced lupus nephritis in mice and promote renal LC3‐associated autophagy
por: Liu, Ruihua, et al.
Publicado: (2023)

The Gut Bacteria Dysbiosis Contributes to Chronic Graft-Versus-Host Disease Associated With a Treg/Th1 Ratio Imbalance
por: Wang, Yulian, et al.
Publicado: (2022)

慢性移植物抗宿主病（cGVHD）诊断与治疗中国专家共识（2021年版）
Publicado: (2021)

C5 deficiency and C5a or C5aR blockade protects against cerebral malaria
por: Patel, Samir N., et al.
Publicado: (2008)

C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid
por: Hornum, Lars, et al.
Publicado: (2017)

SARS-CoV-2 Infection and Active, Multiorgan, Severe cGVHD After HSCT for Adolescent ALL: More Luck Than Understanding? A Case Report
por: Zubarovskaya, Natalia, et al.
Publicado: (2022)

Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation
por: Zhao, Yanmin, et al.
Publicado: (2021)

A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia
por: Weng, Jianyu, et al.
Publicado: (2018)

Correction to: A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia
por: Weng, Jianyu, et al.
Publicado: (2019)

Reduced Risk of Chronic Graft-Versus-Host Disease (cGVHD) by Rabbit Anti-Thymocyte Globulin (ATG) in Patients Undergoing Matched Sibling Donor Transplantation in Hematological Malignancies
por: Fang, Shu, et al.
Publicado: (2022)

Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections
por: Muenstermann, Marcel, et al.
Publicado: (2019)

Deep learning-based transcriptome model predicts survival of T-cell acute lymphoblastic leukemia
por: Zhang, Lenghe, et al.
Publicado: (2022)

C-Type Lectin-Like Molecule-1 as a Biomarker for Diagnosis and Prognosis in Acute Myeloid Leukemia: A Preliminary Study
por: Wang, Jinghua, et al.
Publicado: (2021)

C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis
por: Zheng, Quan-you, et al.
Publicado: (2019)

Role of C5a and C5aR in doxorubicin-induced cardiomyocyte senescence
por: Wen, Yahui, et al.
Publicado: (2021)

Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV
por: Jiang, Yuting, et al.
Publicado: (2018)

Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors
por: Colley, Caroline S., et al.
Publicado: (2017)

Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance
por: Lawal, Bashir, et al.
Publicado: (2021)

Dynamics of PD-1 expression are associated with treatment efficacy and prognosis in patients with intermediate/high-risk myelodysplastic syndromes under hypomethylating treatment
por: Geng, Suxia, et al.
Publicado: (2022)

The “C3aR Antagonist” SB290157 is a Partial C5aR2 Agonist
por: Li, Xaria X., et al.
Publicado: (2021)

Phenotype of mesenchymal stem cells from patients with myelodyplastic syndrome maybe partly modulated by decitabine
por: Pang, Yanbin, et al.
Publicado: (2019)

Association of Immune and Metabolic Receptors C5aR and C5L2 with Adiposity in Women
por: Poursharifi, Pegah, et al.
Publicado: (2014)

The Controversial C5a Receptor C5aR2: Its Role in Health and Disease
por: Zhang, Ting, et al.
Publicado: (2017)

The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics
por: Woodruff, Trent M., et al.
Publicado: (2020)

Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis
por: Carvelli, Julien, et al.
Publicado: (2020)

Role of C5aR1 and C5L2 Receptors in Ischemia-Reperfusion Injury
por: Arias-Cabrales, Carlos, et al.
Publicado: (2021)

Modulation of C5a–C5aR1 signaling alters the dynamics of AD progression
por: Carvalho, Klebea, et al.
Publicado: (2022)

Down-Regulation of C3aR/C5aR Inhibits Cell Proliferation and EMT in Hepatocellular Carcinoma
por: Chen, Bendong, et al.
Publicado: (2020)

Differential effects of C5a on human and mouse mast cells may be mediated by C5aR and C5L2
por: Pundir, P, et al.
Publicado: (2010)

C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer
por: Zhang, Chen, et al.
Publicado: (2023)

C3aR and C5aR1 act as key regulators of human and mouse β-cell function
por: Atanes, Patricio, et al.
Publicado: (2017)

Corrigendum to “The Controversial C5a Receptor C5aR2: Its Role in Health and Disease”
por: Zhang, Ting, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9m0bu4auo6hp66rrpvnj61cu1u